source
- Mirador Therapeutics announces partnership to acquire Kira drug, positioning it against TavneosMirador Therapeutics, a San Diego‑based biotech focused on immune diseases and backed by more than $650 million in venture capital, has disclosed a new element of its development pipeline. The com…
- Alzheimer researcher Betty Tijms urges broader view beyond amyloid and tauBetty Tijms, head of science at the Alzheimer Center Amsterdam, says it is time to stop treating Alzheimer’s as a single disease. For more than a century, research has focused on two proteins, amy…